» Articles » PMID: 7952544

Passive Smoking Exposure in Adults and Chronic Respiratory Symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team

Overview
Specialty Critical Care
Date 1994 Nov 1
PMID 7952544
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The association between passive exposure to tobacco smoke and respiratory symptoms was examined in a sample of 4,197 never-smoking adults. They constituted the never-smoking subsample of a random sample of 9,651 adults (age, 18 to 60 yr) in eight areas in Switzerland. Information on passive smoking exposure and standardized questions on respiratory symptoms were obtained via a questionnaire administered by trained examiners. After controlling for age, sex, body mass index (BMI), study area, atopy, and parental and sibling history, passive smoking exposure was associated with an elevated risk of wheezing apart from colds (odds ratio [OR] = 1.94, 95% CI = 1.39 to 2.70), an elevated risk of bronchitis symptoms (OR = 1.59, 95% CI = 1.17 to 2.15), an elevated risk of symptoms of chronic bronchitis (OR = 1.65, 95% CI = 1.28 to 2.16), an elevated risk of dyspnea (OR = 1.45, 95% CI = 1.20 to 1.76), and an elevated risk of physician diagnosed asthma (OR = 1.39, 95% CI = 1.04 to 1.86). It was not associated with any increased risk of allergic rhinitis including hayfever. Adding a variable for low educational level, excluding subjects whose mother ever smoked or subjects with end-expiratory CO levels > or = 7 ppm, and controlling for paternal smoking during childhood or occupational exposure had little impact on the association. The association of passive smoking exposure with dyspnea, wheeze, and asthma showed evidence of a dose-dependent increase with hours per day of exposure, whereas association with symptoms of bronchitis was stronger with years of exposure.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Longitudinal analysis of the impact of smoking exposure on atopic indices and allergies in early childhood.

Wang Y, Yeh K, Huang J, Su K, Tsai M, Hua M World Allergy Organ J. 2023; 16(7):100802.

PMID: 37520613 PMC: 10374959. DOI: 10.1016/j.waojou.2023.100802.


Prevalence of respiratory diseases in relation to smoking rate in adults living in four Chinese cities: a comparison between 2017-2018 and 1993-1996.

Yan M, Gong J, Liu Q, Li W, Duan X, Cao S J Thorac Dis. 2020; 12(10):6315-6326.

PMID: 33209471 PMC: 7656329. DOI: 10.21037/jtd-19-crh-aq-002.


Suppressive effect of environmental tobacco smoke on murine Th2 cell-mediated nasal eosinophilic inflammation.

Nishimura T, Kaminuma O, Saeki M, Kitamura N, Mori A, Hiroi T Asia Pac Allergy. 2020; 10(2):e18.

PMID: 32411583 PMC: 7203434. DOI: 10.5415/apallergy.2020.10.e18.


Epidemiological evidence relating environmental smoke to COPD in lifelong non-smokers: a systematic review.

Lee P, Forey B, Coombs K, Hamling J, Thornton A F1000Res. 2020; 7:146.

PMID: 32089819 PMC: 6953425. DOI: 10.12688/f1000research.13887.3.


Interventions to reduce ambient particulate matter air pollution and their effect on health.

Burns J, Boogaard H, Polus S, Pfadenhauer L, Rohwer A, van Erp A Cochrane Database Syst Rev. 2019; 5:CD010919.

PMID: 31106396 PMC: 6526394. DOI: 10.1002/14651858.CD010919.pub2.